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Abstract
Background: Acanthamoebae polyphaga Mimivirus (APM) is the largest known dsDNA virus. The
viral particle has a nearly icosahedral structure with an internal capsid shell surrounded with a
dense layer of fibrils. A Capsid protein sequence, D13L, was deduced from the APM L425 coding
gene and was shown to be the most abundant protein found within the viral particle. However this
protein remained poorly characterised until now. A revised protein sequence deposited in a
database suggested an additional N-terminal stretch of 142 amino acids missing from the original
deduced sequence. This result led us to investigate the L425 gene structure and the biochemical
properties of the complete APM major Capsid protein.
Results: This study describes the full length 3430 bp Capsid coding gene and characterises the 593
amino acids long corresponding Capsid protein 1. The recombinant full length protein allowed the
production of a specific monoclonal antibody able to detect the Capsid protein 1 within the viral
particle. This protein appeared to be post-translationnally modified by glycosylation and
phosphorylation. We proposed a secondary structure prediction of APM Capsid protein 1
compared to the Capsid protein structure of Paramecium Bursaria Chlorella Virus 1, another member
of the Nucleo-Cytoplasmic Large DNA virus family.
Conclusion: The characterisation of the full length L425 Capsid coding gene of Acanthamoebae
polyphaga Mimivirus provides new insights into the structure of the main Capsid protein. The
production of a full length recombinant protein will be useful for further structural studies.
Background
Acanthamoebae polyphaga Mimivirus was described for the
first time in 2003 [1]. It was isolated from amoebae grow-
ing in water sample from a cooling tower during an out-
break of pneumonia in an English hospital. Compared to
other members of the Nucleo-Cytoplasmic Large DNA
Viruses (NCLDV) family [2], APM has very particular char-
acteristics due to its size, structure, genome sequence [3],
and replication cycle through a specific virus factory [4].
The virus particle was shown to be icosahedral, with a cap-
sid shell diameter of 5000 Å covered by long fibers and
appears to have at least two lipid membranes beneath its
Capsid protein [5]. The APM 1.2-Mb genome encodes at
least 911 proteins [Genbank: NC_006450] [6]. Proteomic
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analysis of proteins extracted from purified viral particles
allowed the identification of 114 proteins including the
Capsid protein D13L, coded by the L425 gene. The D13L
Capsid protein was shown to be the most abundant and
major glycoprotein of APM [7] and is thought to be the
main component of the outermost protein shell layer. The
protein sequence was deduced from the first available
Methionine codon in the L425 open reading frame.
Recently, based on mass spectrometry analysis of the Cap-
sid protein D13L peptides, the original protein sequence
was revised and completed with 142 supplementary N-
terminal amino-acids (AA) [UniProtKB: Q5UQL7] [8]
and thereafter named here Capsid protein 1. The aim of
this study was to characterize the full length APM Capsid
protein 1 coding gene and to provide new insights into
the structure of the protein. Blast of the Capsid protein 1
coding sequence on the APM genome sequence revealed
that the start codon might be located 2042 bp upstream
from the start codon of the previously annotated L425
coding gene. We produced a recombinant full length Cap-
sid protein 1 and specific monoclonal antibodies (mAb)
that might be useful to develop further structural analysis
or detection assays.
Methods
cDNA cloning and sequencing
Total RNA from uninfected or APM infected A. polyphaga
was extracted using RNeasy extraction kit (Qiagen) as pre-
viously described [3]. The Capsid protein 1 cDNA was
synthsesized from APM infected A. polyphaga RNA by
using the Superscript One-Step RT-PCR with Platinum
Taq kit (Invitrogen) with the following primers:
Q5UQL7NcoIF: 5'-GAAGGAGATATACCATGGCAGGT-
GGTTTACTCCAATTA-3' and Q5UQL7SmaIR: 5'-
GATGAGAACCCCCCCCGGGATTACTG-
TACGCTAATCCG-3'. Underlined are the APM L425 gene
specific sequences: nt 560 926 – 560 449 for the forward
primer; nt 557 533 – 557 515 for the reverse primer. The
resulting 1782 bp cDNA fragment was then cloned into
the pIVEX 2.3 expression vector (Roche) at the NcoI and
SmaI sites. Recombinant plasmids were selected, purified
and then incorporated into the d-Rhodamine Terminator
Cycle Sequencing Ready Reaction buffer kit with Ampli-
taq Polymerase FS (Applied Biosystems). Reaction prod-
ucts were resolved by using an ABI 3100 automated
sequencer and sequence analysis was performed using the
software package ABI Prism DNA Sequencing Analysis
Software version 3.0 (Applied Biosystems). T7 promoter
and T7 terminator primers were used as well as two primer
pairs targeting internal regions of the cDNA: QUQL7-SF1:
5'-GCTGGCAGTAGTAATTCTGC-3'; QUQL7-SR1: 5'-
GCAGAATTACTACTGCCAGC-3'; and QU5QL7-SF2: 5'-
GAAGGTAATGATGGTAGAAG-3'; QU5QL7-SR2: 5'-
CTTCTACCATCATTACCTTC-3'.
RT-PCR analysis
RNA was extracted from uninfected or APM-infected
amoebae at 0, 2, 4, 8 and 16 hours post infection. 100 ng
of each RNA was submitted to RT-PCR amplification
using the SuperScript One-Step RT-PCR kit (Invitrogen)
with the Q5UQL7NcoIF/Q5UQL7SmaIR primer pair.
cDNA synthesis was performed in one cycle of 30 minutes
at 50°C, 3 minutes at 94°C and subsequent PCR reaction
with 35 cycles of 30 seconds at 94°C, 30 seconds at 60°C,
30 seconds at 72°C, and one cycle of 10 minutes at 72°C.
Amplified products were analysed by electrophoresis on
1% agarose gel. GeneRuler 1 kb DNA ladder (MBI-Fer-
mentas) was used as a DNA size marker.
Expression of the recombinant Capsid protein 1
Expression of the Capsid protein 1 was performed using a
cell-free translation system [9], the High Yield RTS 500
Escherichia coli Circular Template kit (Rapid Translation
System, Roche). Reactions were performed at 30°C for 24
h, with a stirrer speed of 120 rpm, with 15 μg of recom-
binant plasmid used as DNA template. The RTS sample
was then centrifuged for 10 min at 10 000 rpm and the
pellet was resuspended in Laemmli buffer, heated for 5
min at 95°C, resolved by 7.5% SDS-PAGE, followed by
Coomassie blue staining or transfer onto nitrocellulose
membrane for immunoblot analysis using a anti-Histi-
dine monoclonal antibody. The recombinant Capsid pro-
tein 1 was extracted from polyacrylamide gels by the
electroelution method using the ElutaTube™ Protein
Extraction Kit (Fermentas Life Sciences) according to the
manufacturer's protocol and used to immunise mice for
the production of monoclonal antibodies.
Monoclonal antibodies production
Three six week-old female BALB/c mice were inoculated
three times intraperitoneally at 14-days interval with 2 μg
electroeluted protein mixed with 400 μg aluminium
hydroxide and 10 μg CpG as previously described [10].
Four days after the last immunisation, spleen cells fusion
was performed with X63.Ag 8.653 myeloma cells (2:1)
using 50% 1500 polyethylene glycol (Roche). Cells were
grown in RPMI medium (Invitrogen) with 15% heat inac-
tivated fetal calf serum (Invitrogen) and hypoxanthine-
aminopterin-thymidine selective medium (Invitrogen) at
37°C with 5% CO2. Hybridoma supernatants were
screened 10 days after by ELISA using plates coated over-
night with 10 μg/ml of APM extract in sodium carbonate
buffer 100 mM, pH 9.6. Positive hybridomas were sub-
cloned by limiting dilution and submitted to isotyping
using a mouse monoclonal isotyping kit (Sigma-Aldrich).
Hybridomas producing the highest mAb titers were then
subcloned, expanded, and tested by Western blot analysis
using APM extract subjected to 2D gel electrophoresis and
transferred onto nitrocellulose.BMC Molecular Biology 2009, 10:39 http://www.biomedcentral.com/1471-2199/10/39
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2D-gel electrophoresis
APM particles were purified through a 25% sucrose gradi-
ent and APM extract was prepared for 2-D gel electro-
phoresis as previously reported [7]. Immobiline™
DryStrips (7 cm, pH 3–10 GE Healthcare) were rehy-
drated overnight using 125 μl rehydration buffer [8 M
urea, 2% (w/v) CHAPS, 60 mM DTT, 0,5% (v/v) IPG
buffer (GE Healthcare)] containing 20 μg of solubilized
APM proteins and IEF was carried out according to the
manufacturer's protocol (IPGphor II, GE Healthcare).
Before the second dimension electrophoresis was per-
formed, strips were equilibrated twice in 5 ml equilibra-
tion buffer [30% (v/v) glycerol, 3% (w/v) SDS, 6 M urea,
50 mM Tris-HCl, bromophenol blue, pH 8.8] for 15 min.
This buffer was supplemented with 65 mM DTT for the
first equilibration and with 100 mM iodoacetamide for
the second one. The strips were then embedded in 0.5%
agarose and the proteins resolved by 10% SDS-PAGE
(Mini-Protean III, Bio-Rad). Gels were stained either with
silver or transferred onto nitrocellulose for Western blot
analysis using Capsid protein 1 specific mAb; anti-Phos-
phothreonine, anti-Phosphotyrosine or anti-Phosphoser-
ine (10-4 dilution, Sigma) mAbs; or rabbit polyclonal
antiserum anti-methylated Lysine (dilution 4.10-2, Bio-
mol GmbH). The detection of glycosylated proteins in 2D
gels was performed according to the Pro-Q Emeral 300
glycoprotein stain kit's procedure (Invitrogen) and visual-
ized using a 300 nm UV illuminator.
Results and discussion
The L425 gene (nt 557 530 – 558 885) was originally
annotated as being the APM D13L Capsid protein coding
sequence. Further mass spectrometry identification of
D13L Capsid peptides allowed Suhre et al. to submit a
protein sequence completed with 142 N-terminal AA [8].
Using TBLASTN [11] the coordinates of the corresponding
nucleotide sequence on the APM genome appeared to be:
nt 560 926 – 560 867 (coding AA 1–18); nt 559 681 – 559
658 (coding AA 19–27) and nt 559 233 – 557 533 (coding
AA 27–593). This result suggested the existence of two
untranslated regions: intron 1, 1188 bp long, (nt 560868
– 559 680) and intron 2, 427 bp long (nt 559 659 – 559
232) (Figure 1A).
Based on this sequence, outermost 5'- and 3'-terminal
primers, Q5UQL7NcoIF and Q5UQL7SmaIR respectively,
were designed to determine the Capsid protein 1 gene
structure. RNA was extracted from APM-infected A. poly-
phaga and used to synthetise full length L425 cDNA. We
then cloned the full-length cDNA into an expression vec-
tor and sequenced the target gene. Comparison of the
cDNA sequence (1782 bp) with the APM genomic DNA
sequence confirmed that the Capsid protein 1 gene is
3430 bp long and consists of three exons interrupted by
two introns (Figure 1A). This result supposed that splicing
events might occur during gene transcription and/or RNA
maturation. To gain insight into this possibility, RT-PCR
analyses were performed on RNA extracted at different
time from APM-infected A. polyphaga using the
Q5UQL7NcoIF/Q5UQL7SmaIR primer pair (Figure 1B).
Agarose gel electrophoresis showed a fragment, about
4000 bp long, amplified from APM genomic DNA (lane
1), and a fragment, about 1800 bp long, from infected cell
RNA (lanes 3–7), while no fragment was amplified from
uninfected cell RNA (lane 2). Only fully spliced mRNA
was detected from t0 to t16 p.i., with an increased signal.
No precursor RNA could be identified. Detection of Cap-
sid protein 1 mRNA as soon as t0 was not surprising since
this RNA was shown to be packaged within the viral par-
ticle [3]. Additional RT-PCR experiments performed using
primer pairs able to detect the potential different forms of
spliced Capsid protein 1 RNA were unsuccessful to dem-
onstrate alternative forms of spliced RNA whatever the
time post-infection (data not shown).
The full length 1782 bp Capsid protein 1 cDNA codes a
593 AA polypeptide with an estimated molecular mass of
67.27 kDa and theoretical isoelectric point of 5.27. The
full length cDNA was cloned into the pIVEX 2.3 expres-
sion vector, producing a C-terminal His-tagged recom-
binant protein. Analysis of the purified recombinant
protein revealed an apparent molecular weight of 69.61
kDa, in accordance with the calculated one (Figure 2).
Expression of Capsid protein 1 was also successful in E.
coli  BL21 (DE3) pLysS. The protein was found in the
unsoluble fraction and Western blot analysis using anti-
His antibodies revealed the same pattern as with the in
vitro translated protein (data not shown).
Analysis of proteins extracted from purified APM particles,
resolved by 2D gel electrophoresis, revealed after silver
staining the typical electrophoresis pattern of APM pro-
teins with the Capsid protein 1 appearing as four spots
under silver staining with an apparent 68.95 kDa molecu-
lar weight (Figure 3A and [7]). Monoclonal antibodies
(mAb) produced against the recombinant full length Cap-
sid protein 1 were used for Western blot analysis of APM
extract resolved by 2D gel analysis and transferred onto
nitrocellulose membranes. The anti-Capsid protein 1
mAb P9A3 recognized the spots previously identified by
mass spectrometry as the Capsid protein D13L (Figure
3B). It was previously shown that rabbit or mouse poly-
clonal antisera prepared against purified viral particles
were unable to recognize any of these spots and that the
D13L capsid protein was shown to be glycosylated [7].
APM Capsid protein 1 contains several Ser, Thr or Asn res-
idues predicted to be N- or O-glycosylated, according to
sequence analysis using the ExPASy proteomics server
(data not shown) [12], but has no signal peptide. The
absence of signal peptide suggests that APM Capsid pro-BMC Molecular Biology 2009, 10:39 http://www.biomedcentral.com/1471-2199/10/39
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tein 1 potential glycosylation sites are unlikely to be
exposed to host cell glycosyltransferases. It has been
shown in the PBCV1 Vp54 Capsid protein that N-glyco-
sylation sites around Asn residues do not obey the consen-
sus NX(T/S) motif, meaning that glycosylation may occur
via the virus encoded glycosyltransferases rather by the
host ones [13]. This may also be the case for APM Capsid
protein 1. Other post-translational modifications were
investigated such as AA phosphorylation or methylation.
APM Capsid protein 1 appeared to be phosphorylated on
Serine (Figure 3C), Threonine or Tyrosine residues but
was not methylated (data not shown).
The former coding sequence assignment for the geneL425
was shown to be homologous to Vp54, the major Capsid
proteins of Paramecium Bursaria Chlorella Virus 1 (PBCV1)
and other large DNA viruses [14]. The full length APM
Capsid protein 1 expressed from the L425 gene exhibited
even higher sequence identity with Vp54 with 46% iden-
tity in the N-terminal region (positions 1–287) and 40%
in the C-terminal region (positions 483–593). The APM
Capsid protein 1 is overall 45% identical to that of the
Chlorella virus PBCV1 [PDB:1J5Q] [15] but 200 amino-
acids are inserted at a position of a stretch of 50 residues
in the Chlorella virus Capsid protein, between Trp264
and Ser315 (Figure 4A). The insertion has several distinct
features: i) it is located at the external face of the APM
Capsid protein 1; ii) it does not belong to the two «jelly
roll» motifs of the core, as found in PBCV1 Capsid pro-
tein; iii) it replaces a group of 4 N-linked sugar, either
because Asn residues are in the deletions/insertions
sequence areas (3 cases) or are absent; and iv) it is pre-
Schematic organisation and expression of the full length L425 gene Figure 1
Schematic organisation and expression of the full length L425 gene. (A) L425 gene (nt 560926 – 557533 position on 
the APM genomic DNA) showed three coding sequences, boxed in grey, separated by two intron sequences. Organisation of 
the corresponding cDNA and 593AA full length protein are shown below. Locations of the former D13L capsid coding 
sequence and corresponding protein are indicated by dotted lines. (B) PCR on APM genomic DNA (lane 1) and RT-PCR analy-
sis on RNA extracted from uninfected (lane 2) or APM-infected amoebae at 0, 2, 4, 8 and 16 h p.i. (lanes 3–7, respectively) 
using 5' Q5UQL7NcoIF and 3' Q5UQL7SmaIR primers. Left lane: DNA size marker.BMC Molecular Biology 2009, 10:39 http://www.biomedcentral.com/1471-2199/10/39
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dominantly structured as a motif of about 10 β-strands
according to the PSIPRED protein structure prediction
server [16-18]. Such a high β-strand contain is reminiscent
of β-sandwich folds. The structure of PBCV1 Capsid is
known [16] and is shown in Figure 4B. This structure is
formed of two «jelly roll» motifs as found in many other
viruses [14]. Compared to the PBCV1 Capsid structure,
the APM CApsid protein 1 insertion might be very proem-
inent. It contains 4 Cysteine residues, on top of the 3
present in the core domain. It should be noticed that
PBCV1 contains only 3 Cysteine residues, none of them
involved in disulfide bridges. The presence of these con-
served domains in the capsid proteins of large dsDNA
viruses strengthens the hypothesis that the capsomer
structure of APM should be similar to other large dsDNA
icosahedral viruses where the capsid proteins assemble
into a pseudo-hexameric capsomer organized into tri- and
pentasymmetrons [19].
Conclusion
Due to an erroneous gene model prediction, the coding
sequence for L425 was wrongly assigned and was until
now only partially described [3]. The full length coding
gene appeared to be composed of three exons separated
by two untranscribed introns. This leads to the synthesis
of a full length 593AA protein translated from a spliced
RNA. This feature seems to be unique to APM since the
PBCV1 A383R or the ASFV B646L capsid coding genes do
not contain intron sequence [20,21]. Tentative bioinfor-
matics analyses of the APM L425 gene introns provided
poor informations about their sequences. Intron 1 (nt
560868 – 559 680) matched with an evalue of 1e-4 to
group I introns while being not related to a specific sub-
group [22,23]. Intron 2 (nt 559 659 – 559 232) did not
show significant match with either group I or group II
introns [22]. Until now, the only other described introns
in APM genome are self-splicing introns present in the
coding sequences of the two largest RNA polymerase sub-
units coding genes L244 and R501 [3].
Rabbit or mouse immune sera produced against purified
APM particles were unable to recognize the Capsid pro-
tein as an antigen in intact viruses, most probably due to
the presence of a dense layer of fibrils surrounding the
capsid shell. The availability of a monoclonal antibody
against Capsid protein 1 might be useful for the develop-
ment of detection assays in clinical samples since APM
might represent a novel human pathogen [24-26].
APM Capsid protein 1 is a glycosylated protein. However
its sequence contained no signal peptide, which makes
the potential glycosylation sites unlikely to be exposed to
the cellular glycosylation machinery. Post-translation
modifications might occur in the virus factory since viral
proteins appeared to be synthesised herein [3,4]. It might
be thought that APM possibly use alternative pathways for
translation and post-translational modifications. Meta-
bolic studies on APM infected amoebae will contribute to
understanding the complex interactions between host and
pathogen. The recombinant full length Capsid protein
might also represent a helpful tool to determine the struc-
tural organisation of APM viral capsid.
Annotation of APM genome revealed 1262 putative ORFs
of length = 100 amino acid residues. 911ORFs were pre-
dicted to be protein coding genes and 298 of them had
functional attributes [3]. Description of the full length
Capsid coding gene and characterisation of the corre-
sponding protein demonstrated that structural and func-
tional studies will contribute to improve our knowledge
of gene composition and expression of such a complex
genome.
Detection of the purified recombinant Capsid protein 1 Figure 2
Detection of the purified recombinant Capsid pro-
tein 1. Either 0.5 or 1 μg of protein (lanes 2 and 3 respec-
tively) was electrophoresed onto 10% SDS-PAGE and 
revealed by Coomassie blue staining (A) or Western-blot 
analysis using anti-Histidine mAb. Standard molecular weight 
markers (lane 1) are indicated on the left.BMC Molecular Biology 2009, 10:39 http://www.biomedcentral.com/1471-2199/10/39
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Two-dimensional gel analysis of APM associated proteins Figure 3
Two-dimensional gel analysis of APM associated proteins. Viral proteins were revealed by silver staining (A); by West-
ern blot analysis using the Capsid protein 1 specific mAb P9A3 (B). Phosphorylated proteins were revealed with anti-Phospho-
serine mAb (C). Standard molecular weight markers are indicated on the left.BMC Molecular Biology 2009, 10:39 http://www.biomedcentral.com/1471-2199/10/39
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